With its acquisition by French drugmaker Sanofi-Aventis a done deal, a Chattem official says it’s on “a full-court press” to start marketing and distributing allergy drug Allegra.
Also, Chattanooga-based Chattem is prepping to sell more of its lineup of consumer products in new markets internationally where Sanofi-Aventis already has a distribution network, said Robert Long, Chattem’s chief financial officer.
In addition, he said Chattem’s expansion on South Broad Street is moving ahead. As many as 60 workers will be hired this year.
“We are making good progress,” he said. “Everything is full steam ahead.”
On Thursday, Paris-based Sanofi-Aventis said it has finalized its $1.9 billion cash acquisition of 130-year-old Chattem, which becomes the French company’s consumer health care division in the United States.